ERBB2 and gastric cancer: Although non-small cell lung cancer, colon, biliary track cancer, urothelial cancer and pancreatic cancers overexpress HER2 protein and/or show gene amplification in diverse proportions of cases, is most prominent in breast and gastric cancers [3].